Kolab

Kolab is a South Korea-based brain health company that combines clinical trial operations with internal product development focused on geriatric brain disorders. The company specializes in subject recruitment, trial planning, monitoring, and clinical execution for neurodegenerative disease and digital medical device studies, leveraging a large dementia cohort dataset from the Gwangju and Jeonnam region. In parallel, Kolab is developing dementia-prevention functional probiotics and live biotherapeutic approaches, and has commercialized or promoted a cognitive health supplement under the name Re:Memo. Its positioning sits at the intersection of SMO/CRO services, cohort-based precision recruitment, and brain-health product development.